Insights into dengue virus genome replication

Future Virology

Volumn 5, Issue 5, 2010, Pages 575-592

  Alcaraz Estrada, Sofia Lizeth ^a   Yocupicio Monroy, Martha ^b   Del Angel, Rosa Mara ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE LA CIUDAD DE MÉXICO   (Mexico)

Author keywords

dengue virus; endoplasmic reticulum; nonstructural proteins; replicative complex; RNA protein interactions; RNA RNA interactions; trans acting factors; viral proteins; viral replicase; viral RNA

Indexed keywords

CIS ACTING ELEMENT; ELONGATION FACTOR 1ALPHA; GENOMIC RNA; LA ANTIGEN; POLYPYRIMIDINE TRACT BINDING PROTEIN; TRANS ACTING FACTOR; Y BOX BINDING PROTEIN 1;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; COMPLEX FORMATION; DENGUE VIRUS; ENDOPLASMIC RETICULUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN RNA BINDING; REVIEW; RNA SYNTHESIS; VIRUS ENVELOPE; VIRUS GENOME; VIRUS MORPHOGENESIS; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

DENGUE VIRUS; RNA VIRUSES;

EID: 77957294373     PISSN: 17460794     EISSN: None     Source Type: Journal    
DOI: 10.2217/fvl.10.49     Document Type: Review

References (172)

1. Guzman G, Kouri G: Dengue: an update. Lancet Infect. Dis. 2, 33-42 (2002).
2. Weaver SC, Reisen WK: Present and future arboviral threats. Antiviral Res. 85, 328-345 (2010).
3. Gubler DJ: Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st Century. Trends Microbiol. 10, 100-103 (2002).
4. Nimmannitya, S: Clinical spectrum and management of dengue haemorrhagic fever. Southeast Asian J. Trop. Med. Public Health 18, 392-397 (1987).
5. Kurane I, Ennis FE: Immunity and immunopathology in dengue virus infections. Semin Immunol. 4, 121-127 (1992).
6. Rothman AL, Ennis FA: Immunopathogenesis of dengue hemorrhagic fever. Virology 257, 1-6 (1999).
7. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS: Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg 40, 444-451 (1989). □□ Describes that dengue antibodies can be neutralizing and, therefore, protect against dengue virus (DENV) infection; however, they can be enhancing and increase the risk of dengue hemorrhagic fever.
8. Rodrigo WW, Jin X, Blackley SD, Rose RC, Schlesinger JJ: Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcy RIA (CD64) or Fcγ RIIA (CD32). J. Virol. 80, 10128-10138 (2006). □ Describes that Fcγ RIA (CD64) or Fcγ RIIA (CD32) mediate enhanced DENV immune complex infectivity, but CD32 appeared to do so far more effectively.
9. Rico-Hesse R: Dengue virus virulence and transmission determinants. Curr. Top. Microbiol. Immunol. 338, 45-55 (2010).
10. Kuhn RJ, Zhang W, Rossman MG et al.: Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108, 717-725 (2002). □□ Determination of the first structure of the DENV particle and the suggestion of a pH-induced class II fusion mechanism by the domain II of the envelope glycoprotein.
11. Li L, Lok SM, Yu IM, et al.: The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science 319, 1830-1834 (2008). □ Provides a crystal structure of the recombinant protein precursor membrane linked to the envelope from DENV providing the identification of the stages of the pH-directed confomational changes during maturation of the viral particle.
12. Crill W, Roehring J: Monoclonal antibodies that bind to domain III of dengue virus e glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J. Virol. 75, 4002-4007 (2001).
13. Rey FA: Dengue virus envelope glycoprotein structure: new insight into its interactions during viral entry. Proc. Natl Acad. Sci. USA 100, 6899-6901 (2003).
14. Modis Y, Ogata S, Clements D, Harrison SC: Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J. Virol. 79, 1223-1231 (2005).
15. Guzman MG, Hermida L, Bernardo L, Ramirez R, Guillén G: Domain III of the envelope protein as a dengue vaccine target. Expert Rev. Vaccines 9, 137-147 (2010).
16. Huang CY, Butrapet S, Moss KJ et al.: The dengue virus type 2 envelope protein fusion peptide is essential for membrane fusion. Virology 396, 305-315 (2010). □ Determination of DENV envelope protein-specific aminoacids, which are essential for cell-to-cell fusion.
17. Ma L, Jones CT, Groesch TD, Kuhn RJ, Post CB: Solution structure of dengue virus capsid protein reveals another fold. Proc. Natl Acad. Sci. USA 101, 3414-3419 (2004).
18. Lindenbach BD, Rice CM: Fields Virology. Knipe DM, Howley PM (Eds). Lippincott Williams & Wilkins, PA, USA 991-1041 (2001).
19. Yu L, Nomaguchi M, Padmanabhan R, Markoff L: Specific requirements for elements of the 5' and 3' terminal regions in flavivirus RNA synthesis and viral replication. Virology 374, 170-185 (2008).
20. Chambers TJ, Hahn CS, Galler R, Rice CM: Flavivirus genome organisation, expression, and replication. Annu. Rev. Microbiol. 44, 649-688 (1990).
21. Falgout B, Pethel M, Zhang YM, Lai CJ: Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J. Virol. 65, 2467-2475 (1991).
22. Cahour A, Falgout B, Lai CJ: Cleavage of the dengue virus polyprotein at the NS3/NS4A and NS4B/NS5 junctions is mediated by viral protease NS2B-NS3, whereas NS4A/NS4B may be processed by a cellular protease. J. Virol. 66, 1535-1542 (1992).
23. Amberg SM, Nestorowicz A, McCourt DW, Rice CM: NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies. J. Virol. 68, 3794-3802 (1994).
24. Falgout B, Markoff L: Evidence that flavivirus NS1-NS2A cleavage is mediated by a membrane-bound host protease in the endoplasmic reticulum. J. Virol. 69, 7232-7243 (1995).
25. Murray JM, Aaskov JG, Wright PJ: Processing of the dengue virus type 2 proteins prM and C-prM. J. Gen. Virol. 74, 175-182 (1993).
26. Stadler K, Allison SL, Schalich J, Heinz FX: Proteolytic activation of tick-borne encephalitis virus by furin. J. Virol. 71, 8475-8481 (1997).
27. Westaway EG, Mackenzie JM, Kenney MT, Jones MK, Khromykh AA: Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures. J. Virol. 71, 6650-6661 (1997). □ Describes that during Kunjin infection, one set of induced membranes comprised vesicle packets of smooth membranes were dual labeled with anti-dsRNA and anti-NS1 or anti-NS3 antibodies, while the presence of NS2B and NS3 was demonstrated in paracrystalline arrays and in convoluted smooth membranes.
28. Mackenzie JM, Khromykh AA, Jones MK, Westaway EG: Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A. Virology 245, 203-215 (1998)
29. Germi R, Crance JM, Garin D et al.: Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus. Virology 292, 162-168 (2002).
30. Jindadamrongwech S, Thepparit C, Smith DR: Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. Arch. Virol. 149, 915-927 (2004).
31. Thepparit C, Smith DR: Serotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor. J. Virol. 78, 12647-12656 (2004).
32. Lozach PY, Burleigh L, Staropoli I et al.: Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals. J. Biol. Chem. 280, 23698-23708 (2005).
33. Reyes-del Valle J, Chávez-Salinas S, Medina F, del Angel RM: Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J. Virol. 79, 4557-4567 (2005).
34. Miller JL, de Wet BJ, Martinez-Pomares L et al.: The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog 4(2), e17 (2008).
35. Stiasny K, Heinz FX: Flavivirus membrane fusion. J. Gen. Virol. 87, 2755-2766 (2006).
36. Krishnan M, Sukumaran B, Agaisse H, Murray J, Hodge T, Fikrig E: Rab 5 is required for the cellular entry of dengue and West Nile viruses. J. Virol. 81, 4881-4885 (2007).
37. van der Schaar HM, Rust MJ, Waarts B-L et al.: Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J. Virol. 81, 12019-12028 (2007).
38. Acosta E, Castilla V, Damonte E: Functional entry of dengue virus into Aedes albopictus mosquito cells is dependent on clathrinmediated endocytosis. J. Gen. Virol. 89, 474-484 (2008).
39. Acosta EG, Talarico LB, Damonte EB: Cell entry of dengue virus. Future Virol. 3, 471-479 (2008).
40. Mosso C, Galván-Mendoza IJ, Ludert JE, del Angel RM: Endocytic pathway followed by dengue virus to infect the mosquito cell line C6/36 HT. Virology 378, 193-199 (2008).
41. van der Schaar HM, Rust MJ, Chen C et al.: Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog. 4(12), e1000244 (2008). □ First study describing the cell entry process of DENV and determines that this virus infects the cell host via a clathrin-mediated endocytosis.
42. Acosta EG, Castilla V, Damonte EB: Alternative infectious entry pathways for dengue virus serotypes into mammalian cells. Cell Microbiol. 11, 1533-1549 (2009). □ Using different approaches this article proposes for the first time that DENV has alternative pathways of entry given by serotype and cell type. These pathways can be either dependent or independent of clathrin, but are always dependent on dynamin.
43. Mackenzie JM, Westaway EG: Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. J. Virol. 75, 10787-10799 (2001).
44. Westaway EG, Khromykh AA, Mackenzie JM: Nascent flavivirus RNA colocalized in situ with double-stranded RNA in stable replication complexes. Virology 258, 108-117 (1999).
45. Uchil PD, Satchidanandam V: Architecture of the flaviviral replication complex - protease, nuclease, and detergents reveal encasement within double-layered membrane compartments. J. Biol. Chem. 278, 24388-24398 (2003). □ The first report providing biochemical evidence of the double-layered membranous compartment of the flavivirus replicative complex.
46. Yu M, Zhang W, Holdaway HA et al.: Structure of immature dengue virus at low pH primes proteolytic maturation. Science 319, 1834-1837 (2008).
47. Wengler G, Castle E: Analysis of structural properties which possibly are characteristic for the 3'-terminal sequence of the genome RNA of flaviviruses. J. Gen. Virol. 67, 1183-1188 (1986).
48. Men RH, Bray M, Clark D et al.: Dengue type 4 virus mutants containing deletions in the 3' noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys. J. Virol. 70, 3930-3937 (1996).
49. Thurner C, Witwer C, Hofacker IL et al.: Conserved RNA secondary structures in Flaviviridae genomes. J. Gen. Virol. 85, 1113-1124 (2004). (Pubitemid 38659775)
50. Yu L, Markoff L: The topology of bulges in the long stem of the flavivirus 3' stem-loop is a major determinant of RNA replication competence. J. Virol. 79, 2309-2324 (2005).
51. Gritsun TS, Gould A: Direct repeats in the 3' untranslated regions of mosquito-borne flaviviruses: possible implications for virus transmission. J. Gen. Virol. 87, 3297-3305 (2006).
52. Clyde K, Harris E: RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication. J. Virol. 80, 2170-2182 (2006).
53. Filomatori CV, Lodeiro MF, Alvarez DE et al.: A 5' RNA element promotes dengue virus RNA synthesis on a circular genome. Genes Dev. 20, 2238-2249 (2006). □□ Describes how the 5-stem-loop A (SLA) element acts as the promoter for DENV RNA synthesis and proposes a novel mechanism for minus-strand RNA synthesis.
54. Dong H, Zhang B, Shi PY: Terminal structures of West Nile virus genomic RNA and their interactions with viral NS5 protein. Virology 381, 123-135 (2008).
55. Villordo SM, Gamarnik AV: Genome cyclization as strategy for flavivirus RNA replication. Virus Res. 139, 230-239 (2009). □□ Provides an insightful review of the elements involved in flavivirus genome cyclization.
56. Lodeiro MF, Filomatori C, Gamarnik AV: Structural and functional studies of the promoter element for dengue virus RNA replication. J. Virol. 83, 93-1008 (2009). □ It presents a detailed study of the structural elements of the 5-SLA required for DENV RNA replication.
57. Khromykh AA, Varnavski AN, Sedlak PL, Westaway EG: Coupling between replication and packaging of flavivirus RNA: evidence derived from the use of DNA-based full-length cDNA clones of Kunjin virus. J. Virol. 75, 4633-4640 (2001).
58. Corver J, Lenches E, Smith K et al.: Fine mapping of a cis-acting sequence element in yellow fever virus RNA that is required for RNA replication and cyclization. J. Virol. 77, 2265-2270 (2003).
59. Alvarez DE, Lodeiro MF, Luduena SJ et al.: Long-range RNA-RNA interactions circularize the dengue virus genome. J. Virol. 79, 6631-6643 (2005). □□ Reports the interaction between the 5-and 3-ends of the DENV genome by atomic force microscopy and the identification of a new set of 16 nucleotides important for RNA-RNA association, termed upstream AUG region.
60. Alvarez DE, De Lella Ezcurra AL, Fucito S, Gamarnik AV: Role of RNA structures present at the 3'UTR of dengue virus on translation, RNA synthesis and viral replication. Virology 339, 200-212 (2005).
61. Kofler RM, Hoenninger VM, Thurner C et al.: Functional analysis of the tick-borne encephalitis virus cyclization elements indicates major differences between mosquito-borne and tick-borne flaviviruses. J. Virol. 80, 4099-4113 (2006).
62. Alvarez DE, Filomatori CV, Gamarnik AV: Functional analysis of dengue virus cyclization sequences located at the 5' and 3'UTRs. Virology 375, 223-235 (2008).
63. Zhang B, Zhou Y, Shi PY: Genetic interactions among the West Nile Virus Methyltransferase, the RNA-dependent RNA polymerase, and the 5' stem-loop of genomic RNA. J. Virol. 82, 7047-7058 (2008).
64. Friebe P, Harris E: The interplay of RNA elements in the dengue virus 5' and 3' ends required for viral RNA replication. J. Virol. 84(12), 6103-6118 (2010).
65. Clyde K, Barrera J, Harris E: The capsidcoding region hairpin element (cHP) is a critical determinant of dengue virus and West Nile virus RNA synthesis. Virology 379, 314-323 (2008).
66. You S, Padmanabhan R: A novel in vitro replication system for dengue virus. Initiation of RNA synthesis at the 3 "-end of exogenous viral RNA templates requires 5"-and 3"-terminal complementary sequence motifs of the viral RNA. J. Biol. Chem. 274, 33714-33722 (1999). □□ This study reports the first in vitro replication assay of DENV using cell-free extracts. It also determines that the interaction between the 5-and 3-ends of the viral genome is modulated by complementary sequences, which are required for the viral RNA synthesis.
67. You S, Falgout B, Markoff L et al.: In vitro RNA synthesis from exogenous dengue viral RNA templates requires long range interactions between 5"-and 3"-terminal regions that influence RNA structure. J. Biol. Chem. 276, 15581-15591 (2001).
68. Tajima S, Nukui Y, Takasaki T et al.: Characterization of the variable region in the 3' non-translated region of dengue type 1 virus. J. Gen. Virol. 88, 2214-2222 (2007).
69. Pankhong P, Ramanathan MP, Weiner DB et al.: Molecular genetic relationship of the 3' untranslated region among Thai dengue-3 virus, Bangkok isolates, during 1973-2000. DNA Cell Biol. 28, 481-491 (2009).
70. Whitehead SS, Falgout B, Hanley KA et al.: A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3' untranslated region is highly attenuated and immunogenic in monkeys. J. Virol. 77, 1653-1657 (2003).
71. Zeng L, Falgout B, Markoff L: Identification of specific nucleotide sequences within the conserved 3"-SL in the dengue type 2 virus genome required for replication. J. Virol. 72, 7510-7522 (1998). □ This study determines that the conservation of the secondary structure and the last 11 nt of the 3-stem loop in DENV genome is required for replication.
72. Tilgner M, Shi PY: Structure and function of the 3' terminal six nucleotides of the West Nile virus genome in viral replication. J. Virol. 78, 8159-8171 (2004).
73. Khromykh AA, Kondratieva N, Sgro JY et al.: significance in replication of the terminal nucleotides of the flavivirus genome. J. Virol. 77, 10623-10629 (2003).
74. Nomaguchi M, Ackermann M, Yon C et al.: De novo synthesis of negative-strand RNA by dengue virus RNA-dependent RNA polymerase in vitro: nucleotide, primer, and template parameters. J. Virol. 77, 8831-8842 (2003).
75. Teramoto T, Kohno Y, Mattoo P et al.: Genome 3"-end repair in dengue virus type 2. RNA 14, 2645-2656 (2008).
76. Ran L, Yue L, Li X et al.: Identification and characterization of small sub-genomic RNAs in dengue 1-4 virus-infected cell cultures and tissues. Biochem. Biophys. Res. Comm. 391, 1099-1103 (2010).
77. Wengler G, Gross HJ: Studies on virus-specific nucleic acids synthesized in vertebrate and mosquito cells infected with flaviviruses. Virology 89, 423-437 (1978).
78. Pijlman GP, Funk A, Kondratieva N et al.: A highly structured, nuclease resistant, noncoding RNA produced by flaviviruses is required for pathogenicity. Cell Host Microbe 4, 579-591 (2008).
79. Mackenzie JM, Jones MK, Young PR: Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology 220, 232-240 (1996).
80. Miller S, Sparacio S, Bartenschlager R: Subcellular localization and membrane topology of the dengue virus type 2 non-structural protein 4B. J. Biol. Chem. 281, 8854-8863 (2006).
81. Miller S, Kastner S, Krijne-Locker J, Buhler S, Bartenschlager R: The nonstructural protein 4A of dengue virus is an integral membrane protein inducing membrane alteration in a 2K-regulated manner. J. Biol. Chem. 282, 8873-8882 (2007).
82. Lindenbach BD, Rice CM: Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function. J. Virol. 73, 4611-4621 (1999).
83. Umareddy I, Chao A, Sampath A, Gu F, Vasudevan SG: Dengue virus NS4B interacts with NS3 and dissociates it from singlestranded RNA. J. Gen. Virol. 87, 2605-2614 (2006).
84. Borowski P, Niebuhr A, Mueller O et al.: Purification and characterization of West Nile virus nucleoside triphosphatase (NTPase)/helicase: evidence for dissociation of the NTPase and helicase activities of the enzyme. J. Virol. 75, 3220-3229 (2001).
85. 2+-dependent and require a functional Walker B motif in the helicase catalytic core. Virology 328, 208-218 (2004).
86. Erbel P, Schiering N, D'Arcy A et al.: Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat. Struct. Mol. Biol. 13, 372-373 (2006).
87. Aleshin AE, Shiryaev SA, Strongin AY, Liddington RC: Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold. Protein Sci. 16, 795-806 (2007).
88. Matusan AE, Pryor MJ, Davidson AD, Wright PJ: Mutagenesis of the dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication. J. Virol. 75, 9633-9643 (2001).
89. Lindenbach BD, Thiel HJ, Rice CM: Fields Virology. Knipe DM, Howley PM (Eds). Lippincott-Raven Publishers, PA, USA 1101-1152 (2007).
90. Koonin EV: Computer-assisted identification of a putative methyltransferase domain in NS5 protein of aviviruses and λ protein of reovirus. J. Gen. Virol. 74, 733-740 (1993).
91. Egloff MP, Benarroch D, Selisko B, Romette JL, Canard B: An RNA cap (nucleoside-2"-O)-methyltransferase in the avivirus RNA polymerase NS5: crystal structure and functional characterization. EMBO J. 21, 2757-2768 (2002).
92. Issur O, Geiss BJ, Bougie I et al.: The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure. RNA 15, 2340-2350 (2009).
93. Tan BH, Fu J, Sugrue RJ, Yap EH, Chan YC, Tan YH: Recombinant dengue type 1 virus Ns5 protein expressed in Escherichia coli exhibits RNA-dependent RNA polymerase activity. Virology 216, 317-325 (1996).
94. Zhou Y, Ray D, Zhao y et al.: Structure and function of flavivirus NS5 methyltransferase. J. Virol. 81, 3891-3903 (2007).
95. Ray D, Shah A, Tilgner M et al.: West Nile virus 5-cap structure is formed by sequential guanine N-7 and ribose 2-O methylations by nonstructural protein 5. J. Virol. 80, 8362-8370 (2006).
96. Dong H, Zhang B, Shi PY: Flavivirus methyltransferase: a novel antiviral target. Antiviral Res. 80, 1-10 (2008). □ Comprehensive review of the methyltransferase activity in West Nile virus.
97. Rawlinson SM, Pryor MJ, Wright PJ, Jans DA: CRM1-mediated nuclear export of dengue virus RNA polymerase NS5 modulates interleukin-8 induction and virus production. J. Biol. Chem. 284, 15589-15597 (2009). □ Describes that NS5 is able to be exported from the nucleus by the exportin CRM1 and, hence, can shuttle between the nucleus and cytoplasm. The nuclear accumulation of NS5 during infection due to CRM1 inhibition coincided with altered kinetics of virus production and decreased induction of the antiviral chemokine IL-8.
98. Kapoor ML, Zhang W, Ramachandra M, Kusukawa J, Ebner KE, Padmanabhan R: Association between NS3 and NS5 proteins of dengue virus type-2 in the putative RNA replicase is linked to differential phosphorylation of NS5. J. Biol. Chem. 270, 19100-19106 (1995).
99. Cui T, Sugrue RJ, Xu Q, Lee AK, Chan YC, Fu J: Recombinant dengue virus type 1 NS3 protein exhibits specific viral RNA binding and NTPase activity regulated by the NS5 protein. Virology 246 409-417 (1998). □ Reports the binding of NS3 to the 3"-untranslated region (UTR) of DENV serotype 1 and provides the first evidence that the NTPAase activity of NS3 is regulated by NS5, suggesting a functional association between these two proteins during virus replication.
100. Bartholomeusz AI, Wright PJ: Synthesis of dengue virus RNA in vitro: initiation and the involvement of proteins NS3 and NS5. Arch. Virol. 128, 111-121 (1993). □□ Reports the inhibition of the conversion of RNA form (RF) to replicative intermediate (RI) using antibodies against NS3 and NS5 in an in vitro replication assay using cell extracts from DENV-infected cells.
101. Raviprakash K, Sinha M, Hayes CG, Porter KR: Conversion of dengue virus replicative form RNA (RF) to replicative intermediate (RI) by nonstructural proteins NS-5 and NS-3. Am. J. Trop. Med. Hyg. 58, 90-95 (1998). □□ Reports the conversion of RF to RI of DENV by NS3 and NS5 and the additive effect when both proteins are present in the reaction.
102. Medin CL, Fitzgerald KA, Rothman AL: Dengue virus nonstructural protein NS5 induces interleukin-8 transcription and secretion. J. Virol. 79, 11053-11061 (2005). □ Describes that transfection of a p las mid expressing NS5 or a DENV replicon induced IL-8 gene expression and secretion; however, RANTES expression was not induced under these conditions.
103. Khabar KS, Al-Zoghaibi F, Al-Ahdal MN et al.: The α chemokine, interleukin 8, inhibits the antiviral action of interferon α. J. Exp. Med. 186, 1077-1085 (1997).
104. Murayama T, Kuno K, Jisaki F et al.: Enhancement human cytomegalovirus replication in a human lung fibroblast cell line by interleukin-8. J. Virol. 68, 7582-7585 (1994).
105. Lane BR, Lore K, Bock PJ et al.: Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J. Virol. 75, 8195-8202 (2001).
106. Polyak SJ, Khalid SA, Khabar DM et al.: Hepatitis C virus nonstructural 5a protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J. Virol. 75, 6095-6106 (2001).
107. Koo BC, McPoland P, Wagoner JP, Kane OJ, Lohmann V, Polyak SJ: Relationships between hepatitis C virus replication and CXCL-8 production in vitro. J. Virol. 80, 7885-7893 (2006).
108. Pryor M, Rawlinso SM, Butcher RE et al.: Nuclear localization of dengue virus nonstructural protein 5 through its importin a/b-recognized nuclear localization sequences is integral to viral infection. Traffic 8, 795-807 (2007).
109. Blackwell JL, Brinton MA: Translation elongation factor-1 α interacts with the 3' stem-loop region of West Nile virus genomic RNA. J. Virol. 71, 6433-6444 (1997).
110. De Nova-Ocampo M, Villegas-Sepuveda N, del Angel RM: Translation elongation factor-1 α, La, and PTB interact with the 3' untranslated region of dengue 4 virus RNA. Virology 295, 337-347 (2002). □ First paper to report the specific interaction of the cellular proteins La, polypyrimidine tract binding protein (PTB) and translation elongation factor-1 α to the 3-UTR of DENV.
111. Li W, Kedersha N, Anderson M et al.: Cell proteins TIA-1 and TIAR interact with the 3' stem-loop of the West Nile virus complementary minus-strand RNA and facilitate virus replication. J. Virol. 76, 11989-12000 (2002).
112. Yocupicio-Monroy RME, Medina F, Reyes-del Valle J et al.: Cellular proteins from human monocytes bind to dengue 4 virus minus-strand 3' untranslated region RNA. J. Virol. 77, 3067-3076 (2003).
113. Garcia-Montalvo BM, Medina F, del Angel RM: La protein binds to NS5 and NS3 and to the 5' and 3' ends of dengue 4 virus RNA. Virus Res. 102, 141-150 (2004). □ Reports the interaction of the cellular protein la to the 5-and 3-UTR of DENV.
114. Paranjape SM, Harris E: Y box-binding protein-1 binds to the dengue virus 3"-untranslated region and mediates antiviral effects. J. Biol. Chem. 282, 30497-30508 (2007). □ Describes the isolation and identification of several host cell factors from BHK cells that bind to the UTR of DENV One identified protein, YB-1, shows a repressive role on DENV translation via a mechanism that requires viral genomic sequences.
115. Lamberti A, Longo O, Marra M et al.: The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis. Amino Acids 26, 443-448 (2004).
116. Blackwell JL, Brinton MA: BHK cell proteins that bind to the 3' stem-loop structure of the West Nile virus genome RNA. J. Virol. 69, 5650-5658 (1995).
117. Das T, Mathur M, Gupta AK et al.: RNA polymerase of vesicular stomatitis virus specifically associates with translation elongation factor-1 a for its activity. Proc. Natl Acad. Sci. USA 95, 1449-1454 (1998).
118. Le Guiner C, Plet A, Galiana D et al.: Polypyrimidine tract-binding protein represses splicing of a fibroblast growth factor receptor-2 gene alternative exon through exon sequences. J. Biol. Chem. 276, 43677-43687 (2001).
119. Castelo-Branco P, Furger A, Wollerton M et al.: Polypyrimidine tract binding protein modulates efficiency of polyadenylation. Mol. Cell. Biol. 24, 4174-4183 (2004).
120. Sawicka K, Bushell M, Spriggs KA et al.: Polypyrimidine-tract-binding protein: a multifunctional RNA-binding protein. Biochem. Soc. Trans. 36, 641-647 (2008).
121. Pautz A, Linker K, Hubrich T et al.: The polypyrimidine tract-binding protein (PTB) is involved in the post-transcriptional regulation of human inducible nitric oxide synthase expression. J. Biol. Chem. 281, 32294-32302 (2006).
122. Back SH, Kim YK, Kim WJ et al.: Translation of polioviral mRNA is inhibited by cleavage of polypyrimidine tract-binding proteins executed by polioviral 3Cpro. J. Virol. 76, 2529-2542 (2002).
123. Song, Y, Tzima E, Ochs K et al.: Evidence for an RNA chaperone function of polypyrimidine tract-binding protein in picornavirus translation. RNA 11, 1809-1824 (2005).
124. Karakasiliotis I, Chaudhry Y, Roberts LO et al.: Feline calicivirus replication: requirement for polypyrimidine tract-binding protein is temperature-dependent. J. Gen. Virol. 87, 3339-3347 (2006).
125. Ali N, Siddiqui A: Interaction of polypyrimidine tract-binding protein with the 5' noncoding region of the hepatitis C virus RNA genome and its functional requirement in internal initiation of translation. J. Virol. 69, 6367-6375 (1995).
126. Kaminski A, Jackson RJ: The polypyrimidine tract binding protein (PTB) requirement for internal initiation of translation of cardiovirus RNAs is conditional rather than absolute. RNA 4, 626-638 (1998).
127. Gosert KH, Rijnbrand R, Yi M et al.: Transient expression of cellular polypyrimidine-tract binding protein stimulates cap-independent translation directed by both picornaviral and flaviviral internal ribosome entry sites in vivo. Mol. Cell. Biol. 20, 1583-1595 (2000).
128. Gontarek RR, Gutshall LL, Herold KM et al.: hnRNP C and polypyrimidine tract-binding protein specifically interact with the pyrimidine-rich region within the 3'NTR of the HCV RNA genome. Nucleic Acids Res. 27, 1457-1463 (1999).
129. Kim SM, Jeong YS: Polypyrimidine tract-binding protein interacts with the 3' stem-loop region of Japanese encephalitis virus negative-strand RNA. Virus Res. 115, 131-140 (2006).
130. Aizaki H, Choi KS, Liu M et al.: Polypyrimidine-tract-binding protein is a component of the HCV RNA replication complex and necessary for RNA synthesis. J. Biomed. Sci. 13, 469-480 (2006).
131. Agis-Juárez RA, Galván I, Medina F et al.: Polypyrimidine tract-binding protein is relocated to the cytoplasm and is required during dengue virus infection in Vero cells. J. Gen. Virol. 90, 2893-2901 (2009). □ Provides evidence that, during DENV infection, PTB moves from the nucleus to the cytoplasm and plays an important role in the DENV replicative cycle.
132. Anwar A, Leong KM, Ng L et al.: The polypyrimidine tract-binding protein is required for effcient dengue virus propagation and associates with the viral replication machinery. J Biol. Chem. 284, 17021-17029 (2009). □ Provides evidence that PTB interacts with the replication complex of DENV and is acting at the level of viral RNA replication.
133. Jiang L, Yao H, Duan X et al.: Polypyrimidine tract-binding protein influences negative strand RNA synthesis of dengue virus. Biochem. Biophys. Res. Com. 385, 187-192 (2009). □ Shows the interaction of DENV NS4A protein with PTB and its role in DENV replication.
134. Florez PM, Sessions OM, Wagner EJ et al.: The polypyrimidine tract binding protein is required for efficient picornavirus gene expression and propagation. J. Virol. 79, 6172-6179 (2005).
135. Karakasiliotis I, Vashist S, Bailey D et al.: Polypyrimidine tract binding protein functions as a negative regulator of feline calicivirus translation. PLoS One 5, e9562 (2010).
136. Choi KS, Huang P, Lai MM: Polypyrimidinetract-binding protein affects transcription but not translation of mouse hepatitis virus RNA. Virology 303, 58-68 (2002).
137. Verma B, Bhattacharyya S, Das S: Polypyrimidine tract-binding protein interacts with coxsackievirus B3 RNA and influences its translation. J. Gen. Virol. 91, 1245-1255 (2010).
138. Tian Q, Taupin J, Elledge S et al.: Fasactivated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis. J. Exp. Med. 182, 865-874 (1995).
139. Candé C, Vahsen N, Métivier D et al.: Regulation of cytoplasmic stress granules by apoptosis-inducing factor. J. Cell Sci. 117, 4461-4468 (2004).
140. Anderson P, Phillips K, Stoecklin G et al.: Post-transcriptional regulation of proinflammatory proteins. J. Leukoc. Biol. 76, 42-47 (2004).
141. Kedersha N, Cho MR, Li W et al.: Dynamic shuttling of Tia-1 accompanies the recruitment of mRNA to mammalian stress granules. J. Cell Biol. 151, 1257-1268 (2000).
142. Yamasaki S, Stoecklin G, Kedersha N et al.: T-cell intracellular antigen-1 (TIA-1)-induced translational silencing promotes the decay of selected mRNAs. J. Biol. Chem. 282, 30070-30077 (2007).
143. Emara MM, Brinton MA: Interaction of TIA-1/TIAR with West Nile and dengue virus products in infected cells interferes with stress granule formation and processing body assembly. Proc. Natl Acad. Sci. USA 104, 9041-9046 (2007).
144. Kuwano M, Oda Y, Izumi H et al.: The role of nuclear Y-box binding protein 1 as a global marker in drug resistance. Mol. Cancer Ther. 3, 1485-1492 (2004).
145. Sarkar SN, Peters KL, Elco CP et al.: Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat. Struct. Mol. Biol. 11, 1060-1067 (2004).
146. Maraia RJ: La protein and the trafficking of nascent RNA polymerase III transcripts. J. Cell Biol. 153, F13-F18 (2001).
147. Kurilla MG, Cabradilla CD, Holloway BP et al.: Nucleotide sequence and host la protein interactions of rabies virus leader RNA. J. Virol. 50, 773-778 (1984).
148. Meerovitch K, Svitkin y V, Lee HS et al.: La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J. Virol. 67, 3798-3807 (1993).
149. De BP, Gupta S, Zhao H et al.: Specific Interaction in vitro and in vivo of glyceraldehyde-3-phosphate dehydrogenase and la protein with cis-acting RNAs of human parainfluenza virus type 3. J. Biol. Chem. 271, 24728-24735 (1996).
150. Waysbort A, Bonnal S, Audigier S et al.: Pyrimidine tract binding protein and la autoantigen interact differently with the 5' untranslated regions of lentiviruses and oncoretrovirus mRNAs. FEBS Lett. 490, 54-58 (2001).
151. Ehlers I, Horke S, Reumann K et al.: Functional characterization of the interaction between human la and hepatitis B virus RNA. J. Biol. Chem. 279, 43437-43447 (2004).
152. Raha T, Pudi R, Das S et al.: Leader RNA of Rinderpest virus binds specifically with cellular la protein: a possible role in virus replication. Virus Res. 104, 101-109 (2004).
153. Pudi R, Abhiman S, Srinivasan N et al.: Hepatitis C virus internal ribosome entry site-mediated translation is stimulated by specific interaction of independent regions of human la autoantigen. J. Biol. Chem. 278, 12231-12240 (2003).
154. Bitko V, Musiyenko A, Bayfield MA et al.: Cellular la protein shields nonsegmented negative-strand RNA viral leader RNA from RIG-I and enhances virus growth by diverse mechanisms. J. Virol. 82, 7977-7987 (2008).
155. Vashist S, Anantpadma M, Sharma H et al.: La protein binds the predicted loop structures in the 3' non-coding region of Japanese encephalitis virus genome: role in virus replication. J. Gen. Virol. 90:1343-1352 (2009).
156. Yocupicio-Monroy M, Padmanabhan R, Medina F et al.: Mosquito la protein binds to the 3' untranslated region of the positive and negative polarity dengue virus RNAs and relocates to the cytoplasm of infected cells. Virology 357, 29-40 (2007). □ Describes that la protein is redistributed in DENV-infected cells from the nucleus to the cytoplasm and the presence of la protein in an in vitro replication system inhibit RNA synthesis in a dose-dependent manner.
157. Salonen A, Ahola T, Kääriäinen L: Viral RNA replication in association with cellular membranes. Curr. Top. Microbiol. Immunol. 285, 139-173 (2005).
158. Miller S, Sparacio S, Bartenschlager R: Subcellular localization and membrane topology of the dengue virus type 2 non-structural protein 4B. J. Biol. Chem. 281, 8854-8863 (2006).
159. Steegmaier M, Oorschot V, Klumperman J, Scheller RH: Syntaxin 17 is abundant in steroigogenic cells and implicated in smooth endoplasmic reticulum membrane dynamics Mol. Biol. Cell 11, 2719-2731 (2000).
160. Mackenzie JM, Jones MK, Westaway EG: Markers for trans-Golgi membranes and the intermediate compartment localize to induced membranes with distinct replication functions in flavivirus-infected cells. J. Virol.. 73, 9555-9567 (1999). □ Determines the cellular origins of viral-induced membranous structures associated with flaviviral RNA synthesis.
161. Chua JJ, Ng MM, Chow VT: The nonstructural 3 (NS3) protein of dengue virus type 2 interacts with human nuclear receptor binding protein and is associated with alterations in membrane structure. Virus Res. 102, 151-163 (2004).
162. Roosendaal J, Westaway EG, Khromykh A, Mackenzie J: Regulated cleavage at the West Nile virus NS4A-2K-NS4B junction play a major role in rearranging cytoplasmic membranes and Golgi trafficking of the NS4A protein. J. Virol. 80, 4623-4632 (2006).
163. Miller S, Kastner S, Krijne-Locker J, Buhler S, Bartenschlager R: The nonstructural protein 4A of dengue virus is an integral membrane protein inducing membrane alteration in a 2K-regulated manner. J. Biol. Chem. 282, 8873-8882 (2007).
164. Welsch S, Miller S, Romero-Brey I et al.: Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe 5, 365-375 (2009). □□ Describes the composition and 3D structure of DENV-induced membranes involved in replication and assembly. It is worth noting that the electron tomography figures showing high quality images of membranous compartments where the replicative cycle takes place.
165. Westaway EG, Khromykh AA, Kenney MT, Mackenzie JM, Jones MK: Proteins C and NS4B of the flavivirus Kunjin translocate independently into the nucleus. Virology 234, 31-41 (1997).
166. Westaway EG, Mackenzie JM, Kenney MT, Jones MK, Khromykh AA: Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA and of NS2B with NS3, in virus-induced membrane structures. J. Virol. 71, 6650-6661 (1997).
167. Samsa MM, Mondotte JA, Iglesias NG et al.: dengue virus capsid protein USURPS lipid droplets for viral particle formation. PLoS Pathog. 5(10), e1000632 (2009). □ Proposes that lipid droplets play multiple roles during the viral lifecycle; they could sequester the viral capsid protein early during infection and provide a scaffold for genome encapsidation.
168. Ye J: Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus. PLoS Pathog 3(8), e108 (2007)
169. Syed GH, Amako Y, Siddiqui A: Hepatitis C virus hijacks host lipid metabolism. Trends Endocrinol. Metab. 21, 33-40 (2010).
170. Rothwell C, Lebreton A, Young Ng C et al.: Cholesterol biosynthesis modulation regulates dengue viral replication. Virology 389, 8-19 (2009). □ Describes that genetic and pharmacological modulation of cholesterol biosynthesis can regulate DENV replication.
171. Ceballos-Olvera I, Chávez-Salinas S, Medina F, Ludert JE, del Angel RM: JNK phosphorylation, induced during dengue virus infection, is important for viral infection and requires the presence of cholesterol. Virology 396, 30-36 (2010).
172. Puerta-Guardo H, Mosso C, Medina F, Liprandi F, Ludert JE, del Angel RM: Antibody-dependent enhancement of dengue virus infection in U937 cells requires cholesterol-rich membrane microdomains. J. Gen. Virol. 91, 394-403 (2010).